237 related articles for article (PubMed ID: 35487312)
1. Therapeutic bispecific antibodies against intracellular tumor antigens.
Xu G; Luo Y; Wang H; Wang Y; Liu B; Wei J
Cancer Lett; 2022 Jul; 538():215699. PubMed ID: 35487312
[TBL] [Abstract][Full Text] [Related]
2. Factors Affecting the Cancer Immunotherapeutic Efficacy of T Cell Bispecific Antibodies and Strategies for Improvement.
Long M; Mims AS; Li Z
Immunol Invest; 2022 Nov; 51(8):2176-2214. PubMed ID: 36259611
[TBL] [Abstract][Full Text] [Related]
3. Antibody-drug conjugates and bispecific antibodies targeting cancers: applications of click chemistry.
Hong Y; Nam SM; Moon A
Arch Pharm Res; 2023 Mar; 46(3):131-148. PubMed ID: 36877356
[TBL] [Abstract][Full Text] [Related]
4. Bispecific antibodies and trispecific immunocytokines for targeting the immune system against cancer: preparing for the future.
Fournier P; Schirrmacher V
BioDrugs; 2013 Feb; 27(1):35-53. PubMed ID: 23329400
[TBL] [Abstract][Full Text] [Related]
5. Overcoming tumor heterogeneity by ex vivo arming of T cells using multiple bispecific antibodies.
Park JA; Cheung NV
J Immunother Cancer; 2022 Jan; 10(1):. PubMed ID: 35086947
[TBL] [Abstract][Full Text] [Related]
6. Bispecific antibodies targeting immunomodulatory checkpoints for cancer therapy.
Zhang T; Lin Y; Gao Q
Cancer Biol Med; 2023 Mar; 20(3):181-95. PubMed ID: 36971124
[TBL] [Abstract][Full Text] [Related]
7. Bispecific antibodies targeting CTLA-4: game-changer troopers in cancer immunotherapy.
Farhangnia P; Ghomi SM; Akbarpour M; Delbandi AA
Front Immunol; 2023; 14():1155778. PubMed ID: 37441075
[TBL] [Abstract][Full Text] [Related]
8. Bispecific antibody based therapeutics: Strengths and challenges.
Thakur A; Huang M; Lum LG
Blood Rev; 2018 Jul; 32(4):339-347. PubMed ID: 29482895
[TBL] [Abstract][Full Text] [Related]
9. Bispecific antibodies targeting dual tumor-associated antigens in cancer therapy.
Huang S; van Duijnhoven SMJ; Sijts AJAM; van Elsas A
J Cancer Res Clin Oncol; 2020 Dec; 146(12):3111-3122. PubMed ID: 32989604
[TBL] [Abstract][Full Text] [Related]
10. Bispecific monoclonal antibodies for targeted immunotherapy of solid tumors: Recent advances and clinical trials.
Hosseini SS; Khalili S; Baradaran B; Bidar N; Shahbazi MA; Mosafer J; Hashemzaei M; Mokhtarzadeh A; Hamblin MR
Int J Biol Macromol; 2021 Jan; 167():1030-1047. PubMed ID: 33197478
[TBL] [Abstract][Full Text] [Related]
11. T Cell-Redirecting Strategies to 'STAb' Tumors: Beyond CARs and Bispecific Antibodies.
Blanco B; Compte M; Lykkemark S; Sanz L; Alvarez-Vallina L
Trends Immunol; 2019 Mar; 40(3):243-257. PubMed ID: 30827461
[TBL] [Abstract][Full Text] [Related]
12. Bispecific antibodies revolutionizing breast cancer treatment: a comprehensive overview.
Lan HR; Chen M; Yao SY; Chen JX; Jin KT
Front Immunol; 2023; 14():1266450. PubMed ID: 38111570
[TBL] [Abstract][Full Text] [Related]
13. Challenges and strategies for next-generation bispecific antibody-based antitumor therapeutics.
Li H; Er Saw P; Song E
Cell Mol Immunol; 2020 May; 17(5):451-461. PubMed ID: 32313210
[TBL] [Abstract][Full Text] [Related]
14. Bispecific, T-Cell-Recruiting Antibodies in B-Cell Malignancies.
Lejeune M; Köse MC; Duray E; Einsele H; Beguin Y; Caers J
Front Immunol; 2020; 11():762. PubMed ID: 32457743
[TBL] [Abstract][Full Text] [Related]
15. Bispecific Antibodies for Non-Hodgkin Lymphoma Treatment.
Bock AM; Nowakowski GS; Wang Y
Curr Treat Options Oncol; 2022 Feb; 23(2):155-170. PubMed ID: 35182296
[TBL] [Abstract][Full Text] [Related]
16. T Cell-Activating Bispecific Antibodies in Cancer Therapy.
Trabolsi A; Arumov A; Schatz JH
J Immunol; 2019 Aug; 203(3):585-592. PubMed ID: 31332079
[TBL] [Abstract][Full Text] [Related]
17. Current landscape and future directions of bispecific antibodies in cancer immunotherapy.
Wei J; Yang Y; Wang G; Liu M
Front Immunol; 2022; 13():1035276. PubMed ID: 36389699
[TBL] [Abstract][Full Text] [Related]
18. Bioassay Development for Bispecific Antibodies-Challenges and Opportunities.
Register AC; Tarighat SS; Lee HY
Int J Mol Sci; 2021 May; 22(10):. PubMed ID: 34069573
[TBL] [Abstract][Full Text] [Related]
19. Bispecific antibodies for targeted delivery of anti-cancer therapeutic agents: A review.
Beishenaliev A; Loke YL; Goh SJ; Geo HN; Mugila M; Misran M; Chung LY; Kiew LV; Roffler S; Teo YY
J Control Release; 2023 Jul; 359():268-286. PubMed ID: 37244297
[TBL] [Abstract][Full Text] [Related]
20. Specific targeting immunotherapy of cancer with bispecific antibodies.
Kudo T; Suzuki M; Katayose Y; Shinoda M; Sakurai N; Kodama H; Ichiyama M; Takemura S; Yoshida H; Saeki H; Saijyo S; Takahashi J; Tominaga T; Matsuno S
Tohoku J Exp Med; 1999 Aug; 188(4):275-88. PubMed ID: 10598685
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
